OOIR: Observatory of International Research

Papers

(The H4-Index of Brain is 72. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Reply: Is postural tachycardia syndrome a psychogenic disorder?; Notes on establishing fear conditioning as causal in the postural orthostatic tachycardia syndrome; Patients with POTS fear that data o	360
Clinical dimensions along the non-fluent variant primary progressive aphasia spectrum	319
Impaired ribosome-associated quality control of C9orf72 arginine-rich dipeptide-repeat proteins	316
Thalamostriatal disconnection underpins long-term seizure freedom in frontal lobe epilepsy surgery	179
Correction to: Variants in the SK2 channel gene (KCNN2) lead to dominant neurodevelopmental movement disorders	178
Methodological drawbacks in the alleged association between foetal sonographic anomalies and autism	173
Proust and his neurologists: the challenge of functional disorders	170
Biallelic ADAM22 pathogenic variants cause progressive encephalopathy and infantile-onset refractory epilepsy	169
Genetically identical twin-pair difference models support the amyloid cascade hypothesis	168
Source-sink connectivity: a novel interictal EEG marker for seizure localization	163
De novo variants in ATXN7L3 lead to developmental delay, hypotonia and distinctive facial features	158
Gain-of-function and loss-of-function variants in GRIA3 lead to distinct neurodevelopmental phenotypes	153
3T MRI of rapid brain activity changes driven by subcallosal cingulate deep brain stimulation	152
Optogenetic stimulation of the superior colliculus suppresses genetic absence seizures	152
Brain repair mechanisms after cell therapy for stroke	148
The axon initial segment as a source of neuropathic pain	146
Clinical and genetic spectrum of 355 Chinese children with epilepsy: a trio-sequencing-based study	142
Choroid plexus mis-splicing and altered cerebrospinal fluid composition in myotonic dystrophy type 1	135
‘Seeding’ the idea of early diagnostics in synucleinopathies	133
Clinical and genetic characterization of a progressive RBL2-associated neurodevelopmental disorder	132
Deep brain stimulation: a tale of two targets … and closing the loop	131
Peripherin is a biomarker of axonal damage in Guillain-Barré syndrome: a pathophysiological annotation	128
We’re all in this together: a rejoinder to Masud Husain’s (rant) editorial	124
Biallelic FRA10AC1 variants cause a neurodevelopmental disorder with growth retardation	124
Distinct subcellular autophagy impairments in induced neurons from patients with Huntington's disease	123

Somatic variants of MAP3K3 are sufficient to cause cerebral and spinal cord cavernous malformations	123
Lesion correlates of impaired acoustic-phonetic perception after unilateral left hemisphere stroke	119
ActivatingRAC1variants in the switch II region cause a developmental syndrome and alter neuronal morphology	118
The vascular contribution of apolipoprotein E to Alzheimer’s disease	116
Brain cholesterol and Alzheimer's disease: challenges and opportunities in probe and drug development	111
Associations between accelerated forgetting, amyloid deposition and brain atrophy in older adults	110
From bugs to brain: unravelling the GABA signalling networks in the brain–gut–microbiome axis	106
‘Hippocampal innate inflammatory gliosis only’ in pharmacoresistant temporal lobe epilepsy	106
The use of optical coherence tomography in neurology: a review	103
Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline	101
Diffusion MRI tracks cortical microstructural changes during the early stages of Alzheimer’s disease	100
Speech and language markers of neurodegeneration: a call for global equity	95
The inferior fronto-occipital fasciculus: bridging phylogeny, ontogeny and functional anatomy	90
Dysfunction of the magnocellular subdivision of the visual thalamus in developmental dyslexia	89
Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson’s disease	87
Dysregulated cortical excitability and tau phosphorylation in a β3 integrin mouse model of autism	86
Mapping the peripheral immune landscape of Parkinson’s disease patients with single-cell sequencing	86
Trigeminal nerve microstructure is linked with neuroinflammation and brainstem activity in migraine	86
18F-MK-6240 tau-PET in genetic frontotemporal dementia	86
Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups	85
Hitching a ride on exosomes: a new approach for the delivery of siRNA-mediated therapies	85
A data-driven study of Alzheimer's disease related amyloid and tau pathology progression	85
Correction to: New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy	85
Multiple sclerosis in Denmark (1950–2023): mean age, sex distribution, incidence and prevalence	84
Clinically relevant mitochondrial-targeted therapy improves chronic outcomes after traumatic brain injury	81
Demystifying interictal discharges and seizure initiation in focal epilepsy	81
Biallelic null variants in PNPLA8 cause microcephaly by reducing the number of basal radial glia	81
Reply: Unblinding in the lecanemab trial in Alzheimer’s disease	81
The three deceits of bureaucracy	79
Intravenous delivery of adeno-associated viral gene therapy in feline GM1 gangliosidosis	79
Integrative genomics reveals pathogenic mediator of valproate-induced neurodevelopmental disability	79
Multimodal mapping of regional brain vulnerability to focal cortical dysplasia	79
Extra-cranial cholinergic lesions in dementia with Lewy bodies	78
Evolutionary perspectives on mRNA signatures of neurodegeneration-related brain remodelling	77
New mechanistic insights into hereditary spastic paraplegias	77
Cytotoxic T cells and plasma cells dominate early in temporal lobe epilepsy with GAD antibodies	77
Functional network reorganization precedes apathy in Parkinson’s disease: a neural marker of risk?	76
GGC repeat expansions in NOTCH2NLC cause uN2CpolyG cerebral amyloid angiopathy	76
Stuttering associated with a pathogenic variant in the chaperone protein cyclophilin 40	75
The low dimensionality of post-stroke cognitive deficits: it’s the lesion anatomy!	75
Preclinical type 2 diabetes mellitus subtypes: new insights into diabetes, depression and dementia	74
Multiple lines of evidence for disruption of nuclear lamina and nucleoporins in FUS amyotrophic lateral sclerosis	74
How COVID-19 affects microvessels in the brain	73
Multicentre analysis of seizure outcome predicted by removal of high-frequency oscillations	73
Extracellular vesicle biomarkers for complement dysfunction in schizophrenia	72
Multifaceted nanoparticles: emerging mechanisms and therapies in neurodegenerative diseases	72
Defective lipid signalling caused by mutations inPIK3C2Bunderlies focal epilepsy	72
Deciphering the impact of coding and non-coding SCN1A gene variants on RNA splicing	72
Hippocampal synaptic failure is an early event in experimental parkinsonism with subtle cognitive deficit	72